KRRO Korro Bio, Inc.
Healthcare$11.61+3.66%ClosedMarket Cap: $115.6M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$19.57
Target (Median)
$22.00
Target Range
$10.00 - $30.00
Upside from current price: 68.6%
Rating Distribution
2 Strong Buy7 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-19 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-13 | Raymond James | upgrade | Outperform | Market Perform |
| 2026-03-13 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2026-02-19 | Clear Street | upgrade | Buy | Hold |
| 2026-02-17 | William Blair | upgrade | Outperform | Market Perform |
| 2026-01-29 | Piper Sandler | upgrade | Overweight | Neutral |
| 2026-01-29 | HC Wainwright & Co. | upgrade | Buy | Neutral |
| 2026-01-29 | Chardan Capital | upgrade | Buy | Neutral |
| 2026-01-28 | Cantor Fitzgerald | upgrade | Overweight | Neutral |
| 2026-01-28 | Oppenheimer | upgrade | Outperform | Perform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-5.16 | $974.1K | 7 |
| Sun Dec 31 | $-5.20 | $1.4M | 7 |
| Mon Dec 31 | $-5.98 | $10.7M | 2 |
| Tue Dec 31 | $-5.83 | $38.6M | 5 |